JOHANNESBURG—South Africa started administering Johnson & Johnson ’s Covid-19 vaccine, which has yet to be authorized anywhere, to healthcare workers, as the country grapples with a new, more contagious coronavirus strain

The South African government scrambled to secure the J&J shots after halting a planned rollout of a vaccine developed by AstraZeneca and the University of Oxford earlier this month. That followed results from a small clinical trial in South Africa that found the AstraZeneca vaccine didn’t appear to protect recipients from developing mild or moderate illness from the fast-spreading new strain of the coronavirus first detected in the country.

The J&J vaccine was found to be 57% effective at preventing moderate and severe Covid-19 symptoms in a larger trial held in South Africa, including from the B.1.351 variant, which has become the predominant version there. That was lower than the 72% efficacy rate observed during J&J’s trial in the U.K., which vaccine experts attributed to the South African variant’s ability to partially escape the immune response triggered by some Covid-19 vaccines.

When looking at just severe Covid-19 cases, the J&J vaccine was found to be 85% effective, including in South Africa.

This post first appeared on wsj.com

You May Also Like

A tragic true story of a gay teen’s suicide and his father’s quest for forgiveness

In April 2013, Joe Bell left his home in La Grande, a…

U.S. Economic Activity Picked Up in Spring, Fed Beige Book Says

Prices rose more rapidly than earlier in the year, according to the…

Unification Church says it took ‘excessive’ donations from mother of suspect in Abe killing

TOKYO — The Unification Church, whose close ties with Japan’s governing party…

State government buildings face bomb threats for second consecutive day

Government buildings across the South received bomb threats on Thursday — the…